Arkolith/Insider Trading/ADIL/Form 4

Young Wendy B.

DirectorADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Jun 16, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 12, 2026Buy(P)36K$2.75$100K36K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-069021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML